by Cefa Cilinas | May 23, 2026 | Blog
The pharmaceutical industry in the United States continues to grow rapidly in 2026, driven by increasing demand for high-quality medicines, advanced drug development, and reliable Active Pharmaceutical Ingredient (API) manufacturing. APIs are the essential components...
by Cefa Cilinas | May 23, 2026 | Blog
India has emerged as one of the world’s leading pharmaceutical manufacturing hubs, supplying high-quality Active Pharmaceutical Ingredients (APIs) to global markets. Among the many essential pharmaceutical compounds, iodine-based APIs play a critical role in the...
by Cefa Cilinas | May 23, 2026 | Blog
India is the third-largest pharmaceutical producer in the world by volume and supplies over 20% of global generic drugs. Behind this success lies a powerful engine: third-party pharma manufacturing companies. These specialized contract manufacturers produce medicines...
by Cefa Cilinas | May 23, 2026 | Blog
Every medicine you take-from a paracetamol tablet to a complex cancer therapy-contains one critical component that makes it work: the Active Pharmaceutical Ingredient (API). Producing that ingredient is one of the most complex and high-stakes operations in pharma. If...
by Cefa Cilinas | May 23, 2026 | Blog
The pharmaceutical industry runs on collaboration as much as on innovation. With the average new drug taking 10–15 years and over $2 billion to develop, no single company, not even Big Pharma can build every promising therapy in-house. That is exactly why in-licensing...
